


CRISM Therapeutics Email Formats
Pharmaceutical Manufacturing • • 1-10 Employees
Key Contact at CRISM Therapeutics
Gerald Beaney
Non Executive Director
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 3254 |
| Keywords | Oncology, Drug Delivery, Prostate Cancer, Cancer, Drug Formulation, Glioblastoma, Rare Cancers, Brain Tumour, Solid Tumours, Chemoseed, Chemotherpay, Localised Treatment |
| Employees | 1-10 |
| Socials |
About CRISM Therapeutics
CRISM Therapeutics Corporation is a UK-based pharmaceutical company which has developed an innovative drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy. ChemoSeed will initially be used to treat glioblastoma, a brain tumour with no satisfactory treatment.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
CRISM Therapeutics has never raised funding before.
CRISM Therapeutics Tech Stack
Discover the technologies and tools that power CRISM Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
PaaS
Blogs
Miscellaneous
Programming languages
Miscellaneous
Security
JavaScript frameworks
Blogs
IaaS
Frequently asked questions
4.8
40,000 users



